Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

SQZ Biotechnologies Company SQZB

Set alert

Price alert · SQZB

All alert types
0.02 USD 0.00 0.00%

At close · Feb 5

0.023 Day range 0.023
0.01 52-week range 0.05
YTD
0.00%
1 year
+4.35%
Open
0.023
Prev close
0.024
Mkt cap
707.79K
Vol
25.00K
Avg vol
20.12K
EPS
-2.08
P/E
0.00
More statistics
Low
0.023
High
0.023

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SQZB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-21.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2018: -16.2×FY 2019: -10.1×FY 2020: -14.2×FY 2021: -3.6×FY 2022: -0.3×
FY 2018 5y median -10.1× FY 2022
P/S 1.0×
FY 2018: 25.8×FY 2019: 16.2×FY 2020: 34.2×FY 2021: 9.1×FY 2022: 1.0×
FY 2018 5y median 16.2× FY 2022
P/B 0.4×
FY 2018: 5.2×FY 2019: 5.6×FY 2020: 5.6×FY 2021: 2.0×FY 2022: 0.4×
FY 2018 5y median 5.2× FY 2022
P/FCF -0.3×
FY 2018: 16.5×FY 2019: -9.2×FY 2020: -16.2×FY 2021: -3.0×FY 2022: -0.3×
FY 2018 5y median -3.0× FY 2022
EV/EBITDA 0.1×
FY 2018: -14.7×FY 2019: -11.0×FY 2020: -14.8×FY 2021: -3.0×FY 2022: 0.1×
FY 2018 5y median -11.0× FY 2022
EV/Sales -0.4×
FY 2018: 21.1×FY 2019: 16.4×FY 2020: 28.3×FY 2021: 6.4×FY 2022: -0.4×
FY 2018 5y median 16.4× FY 2022
FCF Yield -394.3%
FY 2018: 6.1%FY 2019: -10.9%FY 2020: -6.2%FY 2021: -33.6%FY 2022: -394.3%
FY 2018 5y median -10.9% FY 2022

Profitability

Gross Margin 46.6%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 59.3%FY 2022: 46.6%
FY 2018 5y median 100.0% FY 2022
Operating Margin -383.7%
FY 2018: -161.1%FY 2019: -170.4%FY 2020: -243.2%FY 2021: -253.8%FY 2022: -383.7%
FY 2018 5y median -243.2% FY 2022
Net Margin -377.9%
FY 2018: -159.7%FY 2019: -160.1%FY 2020: -240.6%FY 2021: -253.7%FY 2022: -377.9%
FY 2018 5y median -240.6% FY 2022
ROE -139.0%
FY 2018: -32.2%FY 2019: -55.0%FY 2020: -39.7%FY 2021: -55.4%FY 2022: -139.0%
FY 2018 5y median -55.0% FY 2022
ROIC -81.7%
FY 2018: -21.7%FY 2019: -27.7%FY 2020: -26.3%FY 2021: -33.9%FY 2022: -81.7%
FY 2018 5y median -27.7% FY 2022
ROA -74.1%
FY 2018: -17.5%FY 2019: -21.1%FY 2020: -21.9%FY 2021: -30.4%FY 2022: -74.1%
FY 2018 5y median -21.9% FY 2022

Growth (YoY)

Revenue -22.4%
FY 2018: 0.0%FY 2019: 58.7%FY 2020: 4.4%FY 2021: 29.1%FY 2022: -22.4%
FY 2018 FY 2022
Operating Income -17.3%
FY 2018: 0.0%FY 2019: -67.9%FY 2020: -49.0%FY 2021: -34.7%FY 2022: -17.3%
FY 2018 FY 2022
EPS (diluted) -10.8%
FY 2018: 0.0%FY 2019: -59.8%FY 2020: -55.7%FY 2021: -22.1%FY 2022: -10.8%
FY 2018 FY 2022
Free Cash Flow -1.6%
FY 2018: 0.0%FY 2019: -280.2%FY 2020: -24.3%FY 2021: -86.7%FY 2022: -1.6%
FY 2018 FY 2022

Financial Health

Current Ratio 3.1×
FY 2018: 5.1×FY 2019: 2.7×FY 2020: 3.9×FY 2021: 4.5×FY 2022: 3.1×
FY 2018 5y median 3.9× FY 2022
Quick Ratio 3.1×
FY 2018: 5.1×FY 2019: 2.7×FY 2020: 3.9×FY 2021: 4.5×FY 2022: 3.1×
FY 2018 5y median 3.9× FY 2022
Debt / Equity 0.6×
FY 2018: 0.0×FY 2019: 0.7×FY 2020: 0.4×FY 2021: 0.6×FY 2022: 0.6×
FY 2018 5y median 0.6× FY 2022
Net Debt / EBITDA 0.5×
FY 2018: 3.3×FY 2019: -0.1×FY 2020: 3.1×FY 2021: 1.3×FY 2022: 0.5×
FY 2018 5y median 1.3× FY 2022
Interest Coverage 0.0×
FY 2018: -346×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2018 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31